Praxis Precision Medicine Stock (NASDAQ: PRAX)

Praxis Precision Medicine (NASDAQ:PRAX) Stock

Praxis Precision Medicine

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicines Inc

Praxsyn Corp

The CNN Money Fear and Greed index remained in the &#8220;Extreme Fear&#8221; zone on Monday.
U.S. stocks settled lower on Monday, with the Dow Jones index dipping more than 600 points during the session. The S&amp;P 500 also recorded its worst day since December.
US President Donald Trump announced plans to impose 25% tariffs on imports from Canada and Mexico and an additional 20% tariff on goods imported from China, beginning Tuesday.
Most sectors on the S&amp;P 500 closed on a negative note, with information technology, energy and consumer discretionary stocks recording biggest losses on Monday. However, real estate and consumer staples stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 650 points to 43,191.24 on Monday. The S&amp;P 500 fell 1.76% to 5,849.72, while the Nasdaq Composite dipped 2.64% at 18,350.19 during Monday's session.
Investors are awaiting earnings results from Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), AutoZone, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) and Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) today.
At a current reading of 24.4, the index remained in the &#8220;Extreme Fear&#8221; zone on Monday, versus a prior reading of 20.1.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44083539/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

News

Pre-Market Outlook

Markets

Dow Dips Over 600 Points, S&P 500 Records Worst Session Since December; Fear & Greed Index Remains In 'Extreme Fear' Zone

Malaysian Trade Minister Tengku Zafrul Aziz said Tuesday the country will take &#8220;necessary action&#8221; against Malaysian companies if they&#8217;re implicated in a fraud case involving Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chips allegedly routed from Singapore.
What Happened: &#8220;Right now, there&#8217;s no such cases in Malaysia to date, and we are investigating,&#8221; Zafrul <a href="https://www.cnbc.com/2025/03/04/malaysia-says-itll-take-action-if-firms-involved-in-nvidia-fraud-case.html">told</a> CNBC&#8217;s &#8220;Squawk Box Asia,&#8221; adding that Malaysia has no information suggesting data center companies there are misusing chips.
The statement follows Singapore Law Minister K Shanmugam&#8216;s Monday comments that servers in a fraud case may have contained Nvidia AI chips sent to Malaysia.
&#8220;The question is whether Malaysia was a final destination or from Malaysia, it went to somewhere else,&#8221; Shanmugam said.
See Also:&nbsp;<a href="https://www.benzinga.com/personal-finance/25/03/44068159/nba-legend-shaq-says-his-net-worth-quadrupled-once-he-took-note-from-jeff-bezos-and-started-investing-in-things-that-change-peoples-lives" target="_blank" rel="noreferrer noopener">NBA Legend Shaq Says His Net Worth ‘Quadrupled&#8217; Once He Took Note From Jeff Bezos And Started Investing In Things That ‘Change People&#8217;s Lives&#8217;</a>
Why It Matters: On Thursday, Singapore charged three men with fraud in cases linked to the alleged movement of Nvidia chips. According to Shanmugam, the chips were embedded in servers supplied by Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) to Singapore-based companies <a href="https://in.benzinga.com/markets/equities/25/02/44033587/nvidia-chips-smuggled-to-china-3-men-charged-in-singapore-amid-us-export-crackdown">before transfer to Malaysia</a>.
When asked if Malaysia knew where the servers were now, Zafrul replied, &#8220;we don&#8217;t know,&#8221; adding authorities are checking if they went to the right parties.
The investigation emerges amid broader concerns about restricted <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44089103/whats-going-on-with-nvidia-shares-monday">U.S. technology reaching China</a>. Reuters reported in January that the U.S. Commerce Department is investigating whether Chinese AI startup DeepSeek has been using U.S. chips prohibited from export to China, noting &#8220;organized AI chip smuggling to China has been tracked out of countries including Malaysia, Singapore and the United Arab Emirates.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44065932/mark-cuban-was-asked-how-hed-invest-100k-his-answer-buy-bulk-toothpaste-and-soup-for-the-best-guaranteed-return-on-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Was Asked How He&#8217;d Invest $100K — His Answer? Buy Bulk Toothpaste And Soup For The ‘Best Guaranteed Return On Investment&#8217;</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

DELL

NVDA

SMCI

Nvidia Chip Fraud Probe: Malaysia Vows 'Necessary Action' But Admits 'We Don't Know' Where Servers Went

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) to report quarterly earnings at $2.26 per share on revenue of $30.84 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Target shares gained 0.4% to $121.19 in the pre-market trading session.</li>
<li>Analysts are expecting AutoZone, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) to post quarterly earnings at $29.11 per share on revenue of $3.98 billion. The company will release earnings before the markets open. AutoZone shares fell 0.8% to $3,450.00 in the pre-market trading session.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) posted better-than-expected results for its fourth quarter on Monday. Dave shares dipped 5.6% to close at $95.03 on Monday.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Before the markets open, Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) is projected to post quarterly earnings at $2.40 per share on revenue of $13.70 billion. Best Buy shares fell 0.2% to $86.59 in pre-market trading.</li>
<li>Analysts expect Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) to post quarterly earnings at $1.66 per share on revenue of $5.96 billion after the closing bell. Ross Stores shares gained 0.4% to $137.30 in the pre-market trading session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44083539/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Trading Ideas

DAVE

ROST

Target, Best Buy And 3 Stocks To Watch Heading Into Tuesday

ONON

On Confirms 27% Growth Target For Full Year 2025, Projects CHF2.94B In Net Sales, Expects To Maintain Its Gross Profit Margin At Around 60.5%

On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.18 by 111.11 percent. This is a 778.57 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $691.47 million which beat the analyst consensus estimate of $594.49 million by 16.31 percent. This is a 37.13 percent increase over sales of $504.23 million the same period last year.

Earnings Beats

On Holding Q4 Adj EPS $0.38 Beats $0.18 Estimate, Sales $691.47M Beat $594.49M Estimate

Macro Economic Events

Econ #s

Economics

Eurozone Unemployment Rate For January 6.2% Vs. 6.3% Est.; 6.2% (Revised) Prior

Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) rose over 7% in premarket on Tuesday as it is on the verge of finalizing an agreement with private-equity firm Sycamore Partners to take the drugstore chain private. 
What Happened: The deal is approximately valued at $10 billion, according to a <a href="https://www.wsj.com/business/deals/walgreens-nears-roughly-10-billion-deal-to-be-go-private-ee07f2fa">report</a> by the Wall Street Journal. The two parties are reportedly aiming to complete the transaction as early as Thursday, contingent on avoiding any last-minute complications.
Discussions have centered on Sycamore Partners paying between $11.30 and $11.40 per share in cash. The potential deal may also include contingent value rights, which would provide additional value to shareholders if certain performance targets are met in the future, the report stated.
If Sycamore Partners successfully acquires the entire company, the firm intends to retain Walgreens&#8217; core U.S. retail operations. The remaining segments of the company would likely be sold off or taken public.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44101332/sp-500-selloff-spikes-investor-pessimism-bearish-sentiment-hits-30-month-high-but-this-expert-recommends-investors-to-stay-strong-and-not-panic-sell">S&amp;P 500 Selloff Spikes Investor Pessimism: Bearish Sentiment Hits 30-Month High, But This Expert Recommends Investors To &#8216;Stay Strong And Not Panic Sell&#8217;</a>
Why It Matters: According to a mid-December <a href="https://www.benzinga.com/markets/equities/24/12/42431136/walgreens-stock-falls-over-3-in-premarket-as-wall-street-veterans-debate-private-equity-deal-value-amid-sycamore-takeover-talks">report</a> by the Wall Street Journal, Sycamore Partners was in discussions to acquire Walgreens and take the pharmacy chain private, following nearly a decade of declining stock value. 
Price Action: Walgreens fell 3.93% on Monday, underperforming the 2.76% fall in the Fidelity NASDAQ Composite Index ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEQ#NASDAQ">ONEQ</a>), which tracks the Nasdaq Composite index. It was up 7.12% in premarket on Tuesday. 
The stock remains 11.64% higher on a year-to-date basis, however, it&#8217;s down 50.15% over a year.
<a href="https://www.benzinga.com/quote/WBA/analyst-ratings">Benzinga tracks 21 analysts</a> with an average price target of $20.82 for the stock, reflecting a &#8220;sell&#8221; rating. Estimates range widely from $7 to $54. Recent ratings from Deutsche Bank, and Truist Securities average at $11.33, suggesting a potential 5.04% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/WBA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="384" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-1024x384.png" alt="" class="wp-image-807521" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-1024x384.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR-768x288.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04035828/WBA-ANR.png 1065w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44102004/sp-500-vs-us-dollar-while-equities-take-the-tariff-punch-greenback-sheds-tariff-fears-both">S&amp;P 500 Vs US Dollar: While Equities Take The Tariff Punch, Greenback Sheds Tariff Fears: &#8216;Both Can&#8217;t Be Right,&#8217; Says Former Goldman FX Strategist</a></li>
</ul>
Photo courtesy: Walgreens Boots Alliance

Market Summary

Movers & Shakers

Asset Sales

Fidelity NASDAQmposite Index Fund ETF-Tracking NASDAQmposite Index

ONEQ

Walgreens Could Go Private This Week After A $10 Billion Deal With Sycamore Partners: Report

William Blair analyst Max Smock reiterates Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) from Market Perform to Market Perform.

Reiteration

Analyst Ratings

FTRE

William Blair Reiterates Market Perform on Fortrea Holdingsto Market Perform

Canadian Prime Minister Justin Trudeau has announced a 25% tariff on $155 billion worth of U.S. goods. This decision comes as a direct response to the 25% tariffs imposed by U.S. President Donald Trump on Canadian goods.
What Happened: Trudeau has stated that these tariffs will stay in effect until the U.S. reverses its trade measures, <a href="https://www.bnnbloomberg.ca/business/politics/2025/03/04/we-will-be-ready-canada-to-retaliate-with-25-tariffs-on-us-goods-if-trump-follows-through/">reported</a> BNN Bloomberg. The Canadian tariff plan, announced last month, includes two phases targeting a total of $30 billion in U.S. goods initially. An additional round of tariffs on a wider range of American products, worth $125 billion, is scheduled to take effect in 21 days.
Trump&#8217;s initial threat of punitive&nbsp;tariffs on Canadian goods in&nbsp;late November was intended to reduce the influx of illegal migrants and drugs across the border. Despite Canada&#8217;s attempts to delay these tariffs, including a $1.3-billion border plan and the appointment of a &#8220;fentanyl czar&#8221;, Trump confirmed on Monday that Canada will not receive any further reprieves.
According to Reuters, the initial round of retaliation covers over 1200 products, including motorcycles, apparel, wine, coffee, footwear, peanut butter, cosmetics, beer, appliances, spirits, orange juice, and pulp and paper.
Meanwhile, the second tranche could include a diverse selection of U.S. imports including fruits and vegetables, beef, pork, and dairy products, steel and aluminum goods, passenger vehicles and trucks, electric vehicles, and aerospace components.
That being said, Canadian Natural Resources Minister Jonathan Wilkinson is still hopeful of a partnership with the U.S. over critical minerals. Wilkinson stated that his argument to U.S. officials has been that it is much more beneficial to discuss how the U.S. and Canada can support one another.
SEE ALSO: <a href="https://www.benzinga.com/25/03/44101319/pfizer-mulls-us-manufacturing-shift-amid-looming-tariff-threats-will-the-trump-administration-co-invest-asks-analyst">Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: &#8216;Will The Trump Administration Co-Invest&#8217;, Asks Analyst</a>
Why It Matters: The escalating trade war between the U.S. and Canada is a direct result of Trump&#8217;s decision to<a href="https://www.benzinga.com/news/25/03/44092335/trumps-tariffs-threaten-canada-mexico-china-and-american-wallets"> impose 25% </a>tariffs on Canadian imports, as well as 10% duties on energy products from Canada. This move has not only strained relations between the two North American neighbors but also threatens to destabilize the economy.
Ontario Premier&nbsp;Doug Ford&nbsp;has also expressed his readiness to &#8220;respond strongly&#8221; to Trump&#8217;s tariffs,&nbsp;threatening to cut off exports&nbsp;of Ontario nickel, remove American alcohol from liquor store shelves, and cancel provincial government contracts with U.S. companies.
Industry experts and U.S. automakers have opposed Trump&#8217;s tariff plans on multiple occasions. At an investor conference in February, Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) CEO Jim Farley stated &#8220;Long term, a 25% tariff across the Mexico and Canadian border will blow a hole in the U.S. industry that we have never seen.&#8221; Similarly, Bernstein Research has determined that Detroit automakers will be especially vulnerable in comparison to their international rivals. According to another research by the Anderson Economic Group, tariffs may increase manufacturing costs per car by $4,000 to over $10,000, based on the vehicle model.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/bonds/25/03/44096578/leon-cooperman-says-he-likes-cash-calls-trumps-deficit-cutting-contractionary">Leon Cooperman Says He Likes Cash, Calls Trump&#8217;s Deficit Cutting &#8216;Contractionary&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Canadian PM Justin Trudeau Retaliates With 25% Tariffs On US Goods Amid Escalating Trade War

Needham analyst Quinn Bolton maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy and raises the price target from $60 to $66.

Price Target

MCHP

Needham Maintains Buy on Microchip Technology, Raises Price Target to $66

President Donald Trump is set to deliver a highly anticipated address before a joint session of Congress on Tuesday, March 4, outlining his administration's early priorities.
While not formally a State of the Union address, as he has only recently returned to office, the speech is expected to serve a similar function by detailing policy goals and legislative plans.
Notable Attendees And What To Expect
The Vice President JD Vance and Speaker of the House Mike Johnson will be seated behind Trump during the address. One high-profile figure expected to draw attention is Elon Musk.
Trump is expected to outline his administration's key priorities, touching on domestic policies, economic plans, and foreign relations. A major focus will likely be U.S. support for Ukraine, <a href="https://in.benzinga.com/news/global/25/03/44101854/trump-reportedly-halts-ukraine-military-aid-pressures-zelenskyy-to-seek-peace-with-russia-amid-growing-rift">following challenges in negotiations</a> with President Volodymyr Zelensky.&nbsp;
See Also: <a href="https://www.benzinga.com/25/03/44101621/deepseek-loses-top-spot-as-tencents-yuanbao-ai-becomes-no-1-iphone-app-amid-intensifying-ai-battle">DeepSeek Loses Top Spot As Tencent&#8217;s Yuanbao AI Becomes The Top iPhone App In China Amid Intensifying AI Battle</a>
When And Where To Watch
The speech will take place in the House chamber at the U.S. Capitol and will be broadcast live across multiple platforms at 9 PM Eastern Time (ET).
Major television networks, including CNN, PBS, and major news outlets like The New York Times and The Washington Post, will air the event.
Additionally, it will be available for live streaming on platforms such as YouTube, Disney+, Hulu, Peacock and the Associated Press's official channel.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/02/44055314/mrbeast-lost-millions-on-amazons-beast-games-now-hes-looking-to-raise-hundreds-of-millions-to-take-h" target="_blank" rel="noreferrer noopener">MrBeast Lost Millions On Amazon's ‘Beast Games'—Now He's Looking To Raise Hundreds Of Millions To Take His Brand To The Next Level</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Government

Media

Here's How To Watch Donald Trump's Address To Congress: Time, Date, And What To Expect

Accenture Acquires Denmark Based AI Company Halfspace

The newly listed clinical-stage biotechnology company, Metsera Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 15.01% on Monday as the broader markets declined.
What Happened: While the company reported insider trades over the last month after its listing on Jan. 31, the stock has advanced 7.55% since it started trading on Nasdaq.
Founded in 2022 by Population Health Partners and ARCH Venture Partners, the company saw significant insider purchases on Feb. 3.
According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, three insiders acquired a total of $94.22 million worth of Metsera shares at $18 per share. Specifically, Kristina Burow, Managing Director of ARCH Venture Partners, and ARCH Venture Partners itself each acquired 25.75 million shares for $40 million each.
Additionally, Paul L Berns, a Metsera director, purchased 8.31 million shares of common stock for $14.22 million. 
Metsera&#8217;s CEO, Whit Bernard, is scheduled to present at TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44101332/sp-500-selloff-spikes-investor-pessimism-bearish-sentiment-hits-30-month-high-but-this-expert-recommends-investors-to-stay-strong-and-not-panic-sell">S&amp;P 500 Selloff Spikes Investor Pessimism: Bearish Sentiment Hits 30-Month High, But This Expert Recommends Investors To &#8216;Stay Strong And Not Panic Sell&#8217;</a>
Why It Matters: While the markets logged in the worst day of the year on Monday, Metsera rose by 15.01%. The Nasdaq Composite index fell by 2.64% to 18,350.19 and the exchange-traded fund tracking this index, Fidelity NASDAQ Composite Index ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEQ#NASDAQ">ONEQ</a>) slid by 2.76%.
<a href="https://www.benzinga.com/quote/MTSR/analyst-ratings">Benzinga tracks four analysts</a> with an average price target of $47 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $38 to $56. Recent ratings from Guggenheim and BofA Securities suggest a potential 64.91% upside.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="388" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04033515/MTSR-ANR-1024x388.png" alt="" class="wp-image-807493" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04033515/MTSR-ANR-1024x388.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04033515/MTSR-ANR-300x114.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04033515/MTSR-ANR-768x291.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04033515/MTSR-ANR.png 1063w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44070799/mark-cuban-supports-trumps-new-gold-card-scheme-if-sold-to-corporations-for-employee-citizenship-have-a-look-at-the-listed-companies-with-most-number-of-immigrants" target="_blank" rel="noreferrer noopener">Mark Cuban Supports Trump's New ‘Gold Card' Scheme If Sold To Corporations For Employee Citizenship: Here're The Listed-Companies With Most Number Of Immigrants</a></li>
</ul>
Photo courtesy: Shutterstock

MTSR

Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing

SpaceX on Monday canceled Starship&#8217;s eighth flight test merely seconds before liftoff. The company said that it is now ascertaining the next best date for the flight.
What Happened: &#8220;Starship team is determining the next best available opportunity to fly,&#8221; the company said in a post on X, formerly Twitter.
SpaceX CEO Elon Musk said in a post that the company scrapped the flight test because it experienced an issue with the vehicle.
&#8220;Too many question marks about this flight and then we were 20 bar low on ground spin start pressure. Best to destack, inspect both stages and try again in a day or two,&#8221; Musk said, raising hopes of the company attempting the flight before the end of the week. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Too many question marks about this flight and then we were 20 bar low on ground spin start pressure. Best to destack, inspect both stages and try again in a day or two. <a href="https://t.co/TekpJ0uz5y">https://t.co/TekpJ0uz5y</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1896718180695101800?ref_src=twsrc%5Etfw">March 4, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters:&nbsp;For the upcoming test flight, SpaceX is eyeing Starship&#8217;s first payload deployment and experiments aimed at returning the upper stage of the two-stage vehicle to the launch site for catch. The company will also attempt to return and catch the vehicle&#8217;s Super Heavy booster, failing which it will have a soft splashdown in the Gulf of America.
SpaceX will attempt to deploy four Starlink simulators on its next flight, similar in size to the next generation of Starlink satellites.
SpaceX last launched Starship on Jan. 16.&nbsp;The spacecraft lifted off from Starbase in Texas at 4:37 p.m. CT, and the vehicle booster landed back at the launch site after separation from its first stage. The spacecraft, however,&nbsp;<a href="https://www.benzinga.com/25/01/43046722/starship-explodes-during-flight-test-elon-musk-says-success-is-uncertain-but-entertainment-is-guaranteed" target="_blank" rel="noreferrer noopener">disintegrated in space during the flight test owing to a propellant leak.</a>&nbsp;
The upcoming test flight would be Starship&#8217;s eighth to date and second this year. SpaceX started testing Starship in April 2023.
The Starship vehicle is part of big dreams. While NASA is looking forward to landing humans back on the surface of the Moon after a gap of over 50 years with the help of a&nbsp;<a href="https://www.benzinga.com/24/11/42108681/spacex-shows-off-conceptual-version-of-starship-which-will-help-humans-land-back-on-moon-in-over-50-yrs" target="_blank" rel="noreferrer noopener">custom version of Starship</a>, Musk is dreaming of taking&nbsp;<a href="https://www.benzinga.com/news/24/09/40770222/elon-musk-sets-2026-for-starships-first-uncrewed-mars-mission-targeting-successful-landing" target="_blank" rel="noreferrer noopener">humans to the planet Mars</a>&nbsp;aboard Starship. However, the vehicle is currently in the testing and development phase.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44101333/fords-mustang-mach-e-leads-companys-us-ev-sales-in-feb-but-trump-tariffs-threaten-future">Ford&#8217;s Mustang Mach-E Leads Company&#8217;s US EV Sales In Feb But Trump Tariffs Threaten Future</a></li>
</ul>
Photo courtesy: SpaceX

SPACE

SpaceX Scraps Starship Flight Test On Monday: 'Too Many Question Marks About This Flight...,' Says CEO Elon Musk

General

FTI Consulting Subsidiary Compass Lexecon Expands Presence In Italy With New Office In Rome

China has responded forcefully to President Donald Trump&#8217;s recent tariff increases, implementing reciprocal tariffs on selected American goods, sanctioning U.S. companies, and <a href="https://in.benzinga.com/news/25/03/44092335/trumps-tariffs-threaten-canada-mexico-china-and-american-wallets">announcing plans to file a complaint</a> with the World Trade Organization.
What Happened: Beijing&#8217;s actions, timed to coincide with the U.S. doubling of universal tariffs on Chinese goods, include duties of 15% on U.S. poultry and agricultural products such as wheat, corn, and cotton, <a href="https://www.scmp.com/economy/global-economy/article/3300948/china-hits-back-trump-reciprocal-tariffs-sanctions-us-firms?module=top_story&amp;pgtype=homepage">reported</a> South China Morning Post. Tariffs of 10% will be applied to imports of soybeans, pork, beef, and various food products.
&#8220;The unilateral tariff measures launched by the United States seriously violate the rules of the WTO and undermine the basis for bilateral economic and trade cooperation,&#8221; said a Chinese Ministry of Commerce spokesperson in an official statement.
Beyond tariffs, the Ministry of Commerce added 15 U.S. firms to China&#8217;s export control list, requiring special approval for them to receive exports of &#8220;dual-use&#8221; items. Another ten American companies were placed on Beijing&#8217;s &#8220;unreliable entity list,&#8221; effectively banning them from trading with China or making <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43462612/china-retaliatory-tariff-playbook-corn-wheat-soybeans-in-the-crosshairs">new investments in the country</a>.
See Also:&nbsp;<a href="https://www.benzinga.com/personal-finance/25/03/44068159/nba-legend-shaq-says-his-net-worth-quadrupled-once-he-took-note-from-jeff-bezos-and-started-investing-in-things-that-change-peoples-lives" target="_blank" rel="noreferrer noopener">NBA Legend Shaq Says His Net Worth ‘Quadrupled' Once He Took Note From Jeff Bezos And Started Investing In Things That ‘Change People's Lives'</a>
Why It Matters: The escalation follows Trump&#8217;s announcement last week to double tariffs on Chinese imports, augmenting the 10% duties in effect since February. These moves are widely viewed as the opening shots of a new trade war, with Trump signaling on his Truth Social platform that more tariffs could be coming on Apr. 2.
<figure class="wp-block-image aligncenter size-full"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04032944/Screenshot-2025-03-04-at-1.58.41%E2%80%AFPM.png" alt="" class="wp-image-807484" /></figure>
Economists note that while China&#8217;s response is significant, it remains measured. &#8220;Today&#8217;s list covers agricultural goods such as soybeans that are important for trade between the two countries,&#8221; said Zhang Zhiwei, chief economist at Pinpoint Asset Management. &#8220;But China retaliated on a small share of U.S. exports. I think China is still trying not to escalate the trade war.&#8221;
Earlier in February, China had already <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43454424/china-strikes-back-new-tariffs-up-to-15-on-certain-us-imports-in-retaliation-for-trumps-10-levy-on-chinese-goods">imposed 15% tariffs</a> on coal and liquefied natural gas and 10% on crude oil, agricultural machinery, and high-displacement vehicles, affecting major U.S. exporters like Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), and ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44065932/mark-cuban-was-asked-how-hed-invest-100k-his-answer-buy-bulk-toothpaste-and-soup-for-the-best-guaranteed-return-on-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Was Asked How He'd Invest $100K — His Answer? Buy Bulk Toothpaste And Soup For The ‘Best Guaranteed Return On Investment'</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

China Strikes Back At Trump's Tariffs With Retaliatory Duties, US Company Sanctions, And WTO Showdown

Morgan Stanley&nbsp;has reinstated&nbsp;Elon Musk&#8216;s Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)&nbsp;as its top U.S. auto&nbsp;pick, citing the company&#8217;s focus on artificial intelligence and robotics, in a note on Sunday.
What Happened: The endorsement comes despite Tesla&#8217;s recent challenges, including a 45% drop in European sales in January and a decline in 2024 annual deliveries. Analyst Adam Jonas highlighted the company&#8217;s shift from a &#8220;pure automotive play&#8221; to a diversified focus on AI and robotics.
Jonas reiterated his $430 price target for Tesla, making it one of the highest on Wall Street, implying&nbsp;nearly a 51% upside to the&nbsp;stock&#8217;s closing price on Monday. This aligns with CEO Elon Musk&#8217;s strategy of pivoting the company towards AI and robotaxis.
In the research note, Jonas stated that the market potential for non-automotive applications of embodied AI is significantly larger and will be adopted more rapidly than autonomous vehicles. 
&#8220;Humanoid robot opportunity is not in our base or bull case but is becoming serious enough to move the stock. On our calculations, every 1% of U.S. labor force that can be captured by Tesla Optimus is worth approximately $100/TSLA share,&#8221; explained Jonas.
Jonas is also well aware of Tesla&#8217;s challenges as an EV manufacturer. He cautioned in the note, &#8220;EV ‘winter may be prolonged and could still require further steps to mitigate further potential losses near term.&#8221; While Musk expects sales to increase with the introduction of more affordable models, Jonas suggests that deliveries could decrease in 2025, offering an &#8220;attractive entry point&#8221; for investors.
SEE ALSO: <a href="https://www.benzinga.com/25/03/44101621/deepseek-loses-top-spot-as-tencents-yuanbao-ai-becomes-no-1-iphone-app-amid-intensifying-ai-battle">DeepSeek Loses Top Spot As Tencent&#8217;s Yuanbao AI Becomes The Top iPhone App In China Amid Intensifying AI Battle</a>
Why It Matters: Despite these optimistic projections, Tesla&#8217;s stock has underperformed the broader U.S. market, declining nearly 25% year-to-date. The stock fell nearly 40% from its December peak, erasing <a href="https://www.benzinga.com/markets/25/02/44005093/tesla-stock-has-fallen-nearly-40-from-dec-peak-wiping-almost-137-billion-from-elon-musks-wealth">almost $137 billion</a> from CEO Elon Musk&#8217;s wealth. This drop was largely due to a nearly 50% decline in European sales in January, amid potential tariffs and ongoing Musk&#8217;s political involvement in the federal cost-cutting efforts. 
Meanwhile, Tesla Chair Robyn Denholm on Monday sold <a href="https://in.benzinga.com/markets/equities/25/03/44099647/tesla-chair-robyn-denholm-sells-over-30-million-in-shares-as-stock-drops-nearly-3-amid-trump-tariff-concerns#:~:text=Chair%20Robyn%20Denholm%20has%20sold,Tesla%20shares%20over%20recent%20months.">nearly $33.7 million worth of the company&#8217;s stock</a>, as part of a previously adopted trading plan. This sale followed a trend among Tesla insiders offloading shares as the company navigates macroeconomic uncertainties and intensifying competition in the EV market.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/trading-ideas/25/03/44097468/polestar-vs-tesla-can-smaller-ev-company-disrupt-giant-facing-boycotts-protests-with-trade-in-offer">Polestar Vs. Tesla: Can Smaller EV Company Disrupt Giant Facing Boycotts, Protests With &#8216;Trade In&#8217; Offer?</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

TSLA

Tesla On Track For 50% Stock Jump Thanks To AI And Robotics, Says Top Wall Street Analyst: 'Humanoid Robot Serious Enough To Move The Stock'

Investor sentiment is highly disconnected over tariffs as equities and forex markets are showing significant divergence in response to the announcements. This comes amid President Donald Trump's take on yen and yuan's devaluation.
What Happened: According to the senior fellow at the Brookings Institution, Robin Brooks, the divergence in equity and foreign exchange paints two different pictures about the market sentiment on tariffs.
Brooks, formerly the chief FX strategist at Goldman Sachs, highlights that the weakening dollar defies the imposition of "meaningful" tariffs. Whereas, the decline in S&amp;P 500 implies that equities are taking a hit from the tariff news.
"Both can&#8217;t be right," reiterates Brooks in an X post.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Dollar and S&amp;P 500 have completely different takes on looming US tariffs. The Dollar is falling, which means FX markets don&#39;t believe tariffs will be meaningful. The S&amp;P 500 has had a big fall, so it thinks tariffs are about to hit and will stay. Both can&#39;t be right&#8230; <a href="https://t.co/k5bjSed6Pv">pic.twitter.com/k5bjSed6Pv</a>
&mdash; Robin Brooks (@robin_j_brooks) <a href="https://twitter.com/robin_j_brooks/status/1896701660115951689?ref_src=twsrc%5Etfw">March 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, as the U.S. dollar weakens, Trump has said that Japan's and China's plan to devalue their currency in response to tariff threats is "unfair" to the U.S., reported Reuters. According to Trump, the way to solve this problem "very easily is with tariffs."
However, Brooks believes that forex markets have turned agnostic to tariff threats, highlighting that the Mexican peso and Canadian dollar haven't been reacting as well.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Large tariffs are about to hit Mexico and Canada, but FX markets price very little. Mexican Peso is flat since inauguration (lhs, blue), as is Canadian Dollar (rhs, blue). After the back and forth over Mexico and Canada one month ago, markets no longer believe US tariff threats. <a href="https://t.co/ollon4JJkx">pic.twitter.com/ollon4JJkx</a>
&mdash; Robin Brooks (@robin_j_brooks) <a href="https://twitter.com/robin_j_brooks/status/1896695645257478459?ref_src=twsrc%5Etfw">March 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
However, over 120 years, the U.S. dollar remains the most overvalued relative to other fiat currencies, said Otavio Costa, the macro strategist at Crescat Capital in an X post.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is arguably one of the most important charts that I have seen recently.  The US dollar is currently at one of its most overvalued levels relative to other fiat currencies in over 120 years of data.  Comparable extremes in 1933 and 1985 were ephemeral and preceded… <a href="https://t.co/iayj0QqRYu">pic.twitter.com/iayj0QqRYu</a>
&mdash; Otavio (Tavi) Costa (@TaviCosta) <a href="https://twitter.com/TaviCosta/status/1896577902189191547?ref_src=twsrc%5Etfw">March 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/03/44070799/mark-cuban-supports-trumps-new-gold-card-scheme-if-sold-to-corporations-for-employee-citizenship-have-a-look-at-the-listed-companies-with-most-number-of-immigrants">Mark Cuban Supports Trump&#8217;s New &#8216;Gold Card&#8217; Scheme If Sold To Corporations For Employee Citizenship: Here&#8217;re The Listed-Companies With Most Number Of Immigrants</a>
Why It Matters: The implementation of tariffs leads to a stronger domestic currency as imports reduce with higher duties, leading to fewer payments being made to foreign suppliers. However, the dollar index has fallen by 3.27% from its 52-week high of 110.180 to 106.579, as of Monday.
On the other hand, tariffs negatively impact the stock market because the expectation of higher inflation from tariff imposition leads to monetary tightening from the central banks.
While the market sentiment has turned 60.6% bearish according to American Association of Individual Investors survey, the S&amp;P 500 index has slipped 4.84% from its 52-week high of 6,147.43 to 5,849.72, as of Monday. Thus, the stock market is factoring the tariff impact, whereas the dollar remains averse.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Monday. The SPY declined 1.75% to $583.77, and the QQQ dropped 2.19% to $497.05, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44071203/tesla-falls-nearly-23-destroying-354-billion-of-investor-wealth-in-2025-its-only-going-to-get-worse-says-top-investor">Tesla Falls Nearly 23% Destroying $354 Billion Of Investor Wealth In 2025: &#8216;It&#8217;s Only Going To Get Worse,&#8217; Says Top Investor</a></li>
</ul>
Photo courtesy: Shutterstock

Forex

S&P 500 Vs US Dollar: While Equities Take The Tariff Punch, Greenback Sheds Tariff Fears: 'Both Can't Be Right,' Says Former Goldman FX Strategist

<h3>Companies Reporting Before The Bell</h3>
• 908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) is likely to report quarterly loss at $0.37 per share on revenue of $16.18 million. 
• Plug Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) is projected to report quarterly loss at $0.23 per share on revenue of $262.65 million. 
• NexGen Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) is projected to report earnings for its fourth quarter. 
• EVgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $69.00 million. 
• L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) is estimated to report quarterly earnings at $0.22 per share on revenue of $131.48 million. 
• WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $25.59 million. 
• InfuSystems Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INFU#AMEX">INFU</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $34.40 million. 
• Amylyx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) is expected to report earnings for its fourth quarter. 
• Neuronetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) is projected to report quarterly loss at $0.24 per share on revenue of $18.98 million. 
• Y-mAbs Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $26.94 million. 
• Olaplex Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLPX#NASDAQ">OLPX</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $87.51 million. 
• Hagerty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGTY#NYSE">HGTY</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $279.58 million. 
• Angel Oak Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $9.99 million. 
• Esperion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $63.06 million. 
• Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) is expected to report quarterly loss at $0.15 per share on revenue of $17.71 million. 
• Paysafe (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSFE#NYSE">PSFE</a>) is projected to report quarterly earnings at $0.72 per share on revenue of $437.22 million. 
• Compugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEN#NASDAQ">CGEN</a>) is likely to report quarterly loss at $0.07 per share on revenue of $24.96 million. 
• Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) is expected to report quarterly earnings at $0.70 per share on revenue of $4.60 billion. 
• Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) is estimated to report quarterly earnings at $0.07 per share on revenue of $175.71 million. 
• On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $593.34 million. 
• Nayax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $91.89 million. 
• Best Buy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) is likely to report quarterly earnings at $2.42 per share on revenue of $13.69 billion. 
• Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is likely to report quarterly earnings at $2.65 per share on revenue of $30.28 billion. 
• CPI Card (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMTS#NASDAQ">PMTS</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $118.97 million. 
• Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $290.88 million. 
• Modiv Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDV#NYSE">MDV</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $11.86 million. 
• AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) is estimated to report quarterly earnings at $29.90 per share on revenue of $4.00 billion. 
<h3>Companies Reporting After The Bell</h3>
• Medallion Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFIN#NASDAQ">MFIN</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $53.66 million. 
• Southland Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SLND#AMEX">SLND</a>) is projected to report quarterly loss at $0.49 per share on revenue of $230.13 million. 
• Gulf Island Fabrication (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIFI#NASDAQ">GIFI</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $41.00 million. 
• Cumberland (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) is projected to report earnings for its fourth quarter. 
• Baytex Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTE#NYSE">BTE</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $980.40 million. 
• Stellus Cap Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCM#NYSE">SCM</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $26.54 million. 
• ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $26.52 million. 
• Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $57.60 million. 
• Astronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) is likely to report quarterly earnings at $0.28 per share on revenue of $194.91 million. 
• Fuel Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEK#NASDAQ">FTEK</a>) is expected to report quarterly loss at $0.03 per share on revenue of $5.63 million. 
• comScore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) is likely to report quarterly earnings at $0.36 per share on revenue of $91.66 million. 
• Alpha Teknova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $8.78 million. 
• Mayville Engineering (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEC#NYSE">MEC</a>) is projected to report quarterly loss at $0.08 per share on revenue of $124.13 million. 
• NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $21.11 million. 
• ATN International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNI#NASDAQ">ATNI</a>) is projected to report quarterly loss at $0.19 per share on revenue of $179.11 million. 
• Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) is projected to report quarterly loss at $0.16 per share on revenue of $49.37 million. 
• OrthoPediatrics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDS#NASDAQ">KIDS</a>) is projected to report quarterly loss at $0.26 per share on revenue of $52.70 million. 
• Ascent Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNT#NASDAQ">ACNT</a>) is expected to report earnings for its fourth quarter. 
• Ecopetrol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $7.68 billion. 
• Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) is projected to report quarterly earnings at $0.32 per share on revenue of $25.68 million. 
• Owlet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWLT#NYSE">OWLT</a>) is expected to report quarterly loss at $0.48 per share on revenue of $16.92 million. 
• AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) is expected to report quarterly earnings at $0.86 per share on revenue of $214.00 million. 
• Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is estimated to report quarterly earnings at $1.67 per share on revenue of $5.95 billion. 
• Evolus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOLS#NASDAQ">EOLS</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $77.23 million. 
• Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) is expected to report quarterly loss at $0.20 per share on revenue of $6.23 million. 
• CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) is expected to report quarterly loss at $0.31 per share on revenue of $58.79 million. 
• Ingram Micro Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGM#NYSE">INGM</a>) is likely to report quarterly earnings at $0.90 per share on revenue of $13.22 billion. 
• ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) is likely to report quarterly loss at $0.07 per share on revenue of $100.97 million. 
• Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) is estimated to report quarterly earnings at $0.18 per share on revenue of $120.31 million. 
• Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $15.64 million. 
• CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is estimated to report quarterly earnings at $0.86 per share on revenue of $1.03 billion. 
• Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $64.70 million. 
• Custom Truck One Source (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTOS#NYSE">CTOS</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $539.81 million. 
• Cricut (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $214.41 million. 
• Orion Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORN#NYSE">ORN</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $272.70 million. 
• Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) is likely to report quarterly loss at $0.01 per share on revenue of $84.95 million. 
• Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $278.60 million. 
• Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is projected to report quarterly earnings at $0.91 per share on revenue of $223.23 million. 
• Weyco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEYS#NASDAQ">WEYS</a>) is projected to report earnings for its fourth quarter. 
• Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) is likely to report quarterly earnings at $0.84 per share on revenue of $1.13 billion. 
• Nordstrom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) is likely to report quarterly earnings at $0.90 per share on revenue of $4.33 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACNT

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AOMR

ATNI

ATRO

AVAV

CDXC

CGEN

CHPT

CPIX

CRCT

CRDO

CRWD

CTOS

CXDO

CYRX

EOLS

EOSE

ESPR

EVGO

FSTR

FTEK

GENI

GIFI

HGTY

HRZN

INFU

INGM

KIDS

MASS

MFIN

NPCE

Nuveen Arizona Dividend Advantage Municipal Funds 3

NYAX

OLPX

OOMA

OWLT

PLUG

PMTS

PSFE

RIGL

SCOR

SLND

SOPH

STEM

STIM

SWIM

TKNO

WEYS

YMAB

Earnings Scheduled For March 4, 2025

CEVA

Ceva Partners With Arm And SynaXG To Offer A Customized 5G-Advanced Solution For 5G NR Processing In Wireless Network Equipment And Satellites

Health Care

Press Releases

Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

Praxis Precision Medicines to Present at Upcoming December Investor Conferences

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

Praxis Precision Medicines to Present at J.P. Morgan Healthcare Conference

Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities

Praxis Precision Medicines to Present at Two February Investor Conferences

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

Comments

Praxis Precision Medicine

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL